TR201109333T1 - Adefovir dipivoksilin yeni kristal formları ve bunların hazırlama işlemleri. - Google Patents

Adefovir dipivoksilin yeni kristal formları ve bunların hazırlama işlemleri.

Info

Publication number
TR201109333T1
TR201109333T1 TR2011/09333T TR201109333T TR201109333T1 TR 201109333 T1 TR201109333 T1 TR 201109333T1 TR 2011/09333 T TR2011/09333 T TR 2011/09333T TR 201109333 T TR201109333 T TR 201109333T TR 201109333 T1 TR201109333 T1 TR 201109333T1
Authority
TR
Turkey
Prior art keywords
crystal forms
preparation processes
new crystal
adefovir dipivoxil
present
Prior art date
Application number
TR2011/09333T
Other languages
English (en)
Inventor
Goo Lee Byung
Jin Choi Soo
Jin Kim Hye
Tae Kim Yong
Joo Kim Kwang
Soo Oh Seong
Original Assignee
Daewoong Pharmaceutical Co. Ltd.
Daewoong Bio Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co. Ltd., Daewoong Bio Inc. filed Critical Daewoong Pharmaceutical Co. Ltd.
Publication of TR201109333T1 publication Critical patent/TR201109333T1/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bu buluş, kristal 9-[2-[fosfonometoksi]etil]adenin bis-pivaloiloksimetil esterin, yani adefovir dipivoksil, yeni Formları A, B, C, D, E, F ve G ve bunların hazırlanmasına yönelik işlemler ile ilgilidir. Bu buluşa göre, yüksek saflığa sahip olan söz konusu yeni kristal formlar basit bir yöntem ile ve yüksek bir verimde elde edilebilmektedir.
TR2011/09333T 2009-03-26 2010-03-26 Adefovir dipivoksilin yeni kristal formları ve bunların hazırlama işlemleri. TR201109333T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20090025879 2009-03-26

Publications (1)

Publication Number Publication Date
TR201109333T1 true TR201109333T1 (tr) 2012-01-23

Family

ID=42781689

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/09333T TR201109333T1 (tr) 2009-03-26 2010-03-26 Adefovir dipivoksilin yeni kristal formları ve bunların hazırlama işlemleri.

Country Status (8)

Country Link
US (1) US9169257B2 (tr)
EP (1) EP2411392B1 (tr)
JP (1) JP5642766B2 (tr)
KR (1) KR20100108297A (tr)
CN (1) CN102365283B (tr)
RU (1) RU2485121C1 (tr)
TR (1) TR201109333T1 (tr)
WO (1) WO2010110622A2 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071594A1 (it) * 2007-08-02 2009-02-03 Solmag Spa Forma cristallina monoidrata di adefovir dipivoxil
EP2411392B1 (en) 2009-03-26 2014-02-26 Daewoong Pharmaceutical Co., Ltd. Novel crystal forms of adefovir dipivoxil and processes for preparing the same
CN102716136A (zh) * 2012-06-25 2012-10-10 上海益生源药业有限公司 高剂量三斜晶阿德福韦酯制剂、其制备方法及其应用
CN103665044B (zh) * 2013-12-20 2015-07-15 悦康药业集团有限公司 一种阿德福韦酯化合物
CN107663217B (zh) * 2016-07-28 2021-03-02 苏州朗科生物技术股份有限公司 替诺福韦艾拉酚胺结晶化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS263952B1 (en) 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS263951B1 (en) 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
DK0481214T3 (da) 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
KR100700087B1 (ko) 1997-07-25 2007-03-28 길리애드 사이언시즈, 인코포레이티드 뉴클레오티드 동족체의 제조 방법
ZA986614B (en) * 1997-07-25 1999-01-27 Gilead Sciences Nucleotide analog composition
AU2003284800A1 (en) 2002-11-12 2004-06-03 Tianjin Kinsly Pharmaceutical Co., Ltd. A new crystal form of adefovir dipivoxil and its composition
CN1791599A (zh) * 2003-05-21 2006-06-21 贝林格尔.英格海姆国际有限公司 丙型肝炎抑制剂化合物
CN1580060A (zh) * 2004-05-21 2005-02-16 四川倍达尔新技术开发有限公司 药用化合物阿德福韦酯的一种晶体结构及其制备方法和药物
EP2411392B1 (en) 2009-03-26 2014-02-26 Daewoong Pharmaceutical Co., Ltd. Novel crystal forms of adefovir dipivoxil and processes for preparing the same

Also Published As

Publication number Publication date
CN102365283B (zh) 2014-04-09
JP2012521417A (ja) 2012-09-13
JP5642766B2 (ja) 2014-12-17
WO2010110622A2 (en) 2010-09-30
WO2010110622A9 (en) 2011-02-03
RU2485121C1 (ru) 2013-06-20
CN102365283A (zh) 2012-02-29
EP2411392A4 (en) 2012-10-10
US20120101273A1 (en) 2012-04-26
KR20100108297A (ko) 2010-10-06
EP2411392A2 (en) 2012-02-01
US9169257B2 (en) 2015-10-27
EP2411392B1 (en) 2014-02-26
RU2011143166A (ru) 2013-05-10
WO2010110622A3 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
TR201109333T1 (tr) Adefovir dipivoksilin yeni kristal formları ve bunların hazırlama işlemleri.
CR20140132A (es) Derivados de pirrolopirimidina y purina
BR112013001267A2 (pt) métodos para a preparação de pró-fármacos de fosforamidato diasteromericamente puro
CO6831982A2 (es) Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
NZ592125A (en) Use of an oxalic acid dianilide derivative in the production of solar cell modules
MX2012011779A (es) Pirimidinas modificadas en la posicion 5 y su uso.
IN2014DN09244A (tr)
TR201902476T4 (tr) Kaplamalı Substratların Üretim Süreci
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
TR201905687T4 (tr) Travoprost hazırlanışına yönelik proses.
DK2390914T3 (da) Indretning af to forbindelsespartnere med en lavtemperatur-tryksinterforbindelse samt fremgangsmåde til dens fremstilling
MX358775B (es) Prevencion o reduccion de incrustaciones en produccion de acido fosforico de proceso humedo.
MX2016006241A (es) Formas morficas de esteres de hexadeciloxipropil-fosfonato.
EP3760637A3 (en) Stable solid forms of regadenoson
DK2548949T3 (da) Mikroorganisme med forbedret produktion af 5'-xanthosinmonophosphat og 5'-guaninmonophosphat samt fremgangsmåde til fremstilling af 5'-xanthosinmonophosphat og 5'-guaninmonophosphat under anvendelse af samme
MX342273B (es) Proceso para la preparacion de esteres de acido (5-fluoro-2-metil-3-quinolina-2-ilmetil-indol-1-il)-acetico.
PH12014501353A1 (en) Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase
UA106886C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та проміжні сполуки магнію
EA201370151A1 (ru) Высокопродуктивная суспензионная клеточная линия, система и способ ее получения
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
RU2015118152A (ru) Новое сложноэфирное соединение алициклической дикарбоновой кислоты и способ его изготовления
NZ708442A (en) Process for manufacturing biofuels
MX2015001455A (es) Procedimiento multietapa para la preparacion de sales de metales alcalinos de esteres 4-hidroxi-2-oxo-2,5-dihidrofuran-3-carboxilicos especificos.
MY166708A (en) Method for performing a frit firing cycle in the manufacturing of a vacuum solar thermal panel